C12Y 302/01023
Beta-galactosidase , i.e. exo--beta-d-galactanase
Official title: Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
C12Y302/01023 (Beta-galactosidase , i.e. exo--beta-d-galactanase) appears on 401 US grants and 412 published applications in this corpus.
Search patents in C12Y- Granted patents
- 401
- Published applications
- 412
- Assignees
- 253
- Inventors
- 980
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 0 | 0 |
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 7 | 0 |
| 1990 | 4 | 0 |
| 1991 | 5 | 0 |
| 1992 | 3 | 0 |
| 1993 | 4 | 0 |
| 1994 | 4 | 0 |
| 1995 | 9 | 0 |
| 1996 | 4 | 0 |
| 1997 | 14 | 0 |
| 1998 | 24 | 0 |
| 1999 | 12 | 0 |
| 2000 | 12 | 0 |
| 2001 | 17 | 3 |
| 2002 | 17 | 15 |
| 2003 | 10 | 20 |
| 2004 | 6 | 7 |
| 2005 | 4 | 9 |
| 2006 | 9 | 14 |
| 2007 | 4 | 2 |
| 2008 | 3 | 11 |
| 2009 | 4 | 17 |
| 2010 | 7 | 14 |
| 2011 | 8 | 9 |
| 2012 | 11 | 16 |
| 2013 | 13 | 13 |
| 2014 | 10 | 20 |
| 2015 | 14 | 13 |
| 2016 | 13 | 15 |
| 2017 | 11 | 31 |
| 2018 | 13 | 18 |
| 2019 | 12 | 19 |
| 2020 | 13 | 22 |
| 2021 | 11 | 21 |
| 2022 | 16 | 26 |
| 2023 | 11 | 21 |
| 2024 | 11 | 16 |
| 2025 | 22 | 22 |
| 2026 | 12 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Spray-dried composition comprising beta-galactosidase having transgalactosylating activity in combination with maltodextrin and/or NACL and application of the composition18 Aug 2026US 12,708,130 B2International N&H Denmark Aps
- Methods and compositions for treating GM1 gangliosidosis9 Jun 2026US 12,648,978 B2University of Massachusetts
- Engineered microorganisms for synthesis of polyhydroxyalkanoates2 Jun 2026US 12,644,140 B2
- Lactase enzymes with improved properties at acidic PH19 May 2026US 12,630,811 B2Chr. Hansen A/S
- Senescence inhibitor21 Apr 2026US 12,605,421 B2Saisei Pharma Co., Ltd.
- Improved Enzyme Sensor Membrane for Lactose1 Oct 2026US 2026/0297553 A1YSI Incorporated
- Method for the production of d-tagatose using an l-arabinose isomerase from lentilactobacillus parakefiri3 Sep 2026US 2026/0258463 A1
- Protein/oligonucleotide core-shell nanoparticle therapeutics27 Aug 2026US 2026/0248737 A1Northwestern University
- Spray dried milk or milk-based powder composition and methods thereof20 Aug 2026US 2026/0240181 A1Kerry Group Services International Limited
- Nisin-permeabilized microbial cell catalysts13 Aug 2026US 2026/0234688 A1
Most cited
By later US patents
- Methods for in vitro recombination882US 5,605,793 AAffymax Technologies N.V. · 1997
- Methods and compositions for cellular and metabolic engineering844US 5,837,458 AMaxygen, Inc. · 1998
- DNA mutagenesis by random fragmentation and reassembly791US 5,830,721 AAffymax Technologies N.V. · 1998
- Methods for generating polynucleotides having desired characteristics by iterative selection and recombination707US 5,811,238 AAffymax Technologies N.V. · 1998
- Methods for generating polynucleotides having desired characteristics by iterative selection and recombination531US 6,117,679 AMaxygen, Inc. · 2000